Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000287932 is a GENCODE-annotated uncharacterized "novel transcript, sense intronic to CDK6", also referred to as AC000065.2, and corresponds to a non-protein-coding RNA transcribed from within the intronic region of the CDK6 gene on chromosome 7[3]. This transcript is not equivalent to the canonical protein-coding CDK6 (cyclin-dependent kinase 6) gene, for which robust therapeutic targeting, biological function, and disease roles are well established[3][5]. There is currently no publicly available functional or clinical information for this non-coding transcript, and it is not considered a therapeutic target. Key context: - Is it a therapeutic target? No; protein-coding CDK6 is a well-validated cancer target, but this specific transcript is not[3][5]. - Is something wrong with this target? Yes; it is not a well-defined or actionable molecular target, and may be a generic or placeholder description from a transcriptomics dataset[3]. - Aliases: Sometimes referred to by its genome annotation (e.g., AC000065.2)[3]. Note: If you are seeking information on the canonical CDK6 protein ("cyclin-dependent kinase 6"), that is a very different, well-characterized kinase involved in cell cycle control and oncogenesis[2][5][6]. The current identifier (ENSG00000287932) and description refer specifically to a non-coding RNA, not the kinase enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, sense intronic to CDK6.